Logo image of ATS

ATS CORP (ATS) Stock Fundamental Analysis

NYSE:ATS - New York Stock Exchange, Inc. - CA00217Y1043 - Common Stock - Currency: USD

28.79  -0.3 (-1.03%)

After market: 28.79 0 (0%)

Fundamental Rating

3

ATS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. While ATS is still in line with the averages on profitability rating, there are concerns on its financial health. ATS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ATS was profitable.
ATS had a negative operating cash flow in the past year.
ATS had positive earnings in each of the past 5 years.
ATS had a positive operating cash flow in each of the past 5 years.
ATS Yearly Net Income VS EBIT VS OCF VS FCFATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

The Return On Assets of ATS (1.91%) is worse than 60.00% of its industry peers.
ATS's Return On Equity of 5.09% is in line compared to the rest of the industry. ATS outperforms 43.20% of its industry peers.
With a Return On Invested Capital value of 5.46%, ATS perfoms like the industry average, outperforming 41.60% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ATS is below the industry average of 11.00%.
Industry RankSector Rank
ROA 1.91%
ROE 5.09%
ROIC 5.46%
ROA(3y)4.1%
ROA(5y)3.55%
ROE(3y)11.76%
ROE(5y)9.71%
ROIC(3y)7.85%
ROIC(5y)7.1%
ATS Yearly ROA, ROE, ROICATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 3.25%, ATS perfoms like the industry average, outperforming 42.40% of the companies in the same industry.
ATS's Profit Margin has improved in the last couple of years.
ATS's Operating Margin of 8.98% is in line compared to the rest of the industry. ATS outperforms 48.00% of its industry peers.
In the last couple of years the Operating Margin of ATS has grown nicely.
ATS has a Gross Margin of 29.64%. This is comparable to the rest of the industry: ATS outperforms 45.60% of its industry peers.
In the last couple of years the Gross Margin of ATS has grown nicely.
Industry RankSector Rank
OM 8.98%
PM (TTM) 3.25%
GM 29.64%
OM growth 3Y10.39%
OM growth 5Y3.89%
PM growth 3Y12.53%
PM growth 5Y2.52%
GM growth 3Y2.82%
GM growth 5Y1.64%
ATS Yearly Profit, Operating, Gross MarginsATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ATS is destroying value.
Compared to 1 year ago, ATS has more shares outstanding
The number of shares outstanding for ATS has been increased compared to 5 years ago.
Compared to 1 year ago, ATS has an improved debt to assets ratio.
ATS Yearly Shares OutstandingATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ATS Yearly Total Debt VS Total AssetsATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

ATS has an Altman-Z score of 2.06. This is not the best score and indicates that ATS is in the grey zone with still only limited risk for bankruptcy at the moment.
ATS has a Altman-Z score of 2.06. This is in the lower half of the industry: ATS underperforms 61.60% of its industry peers.
ATS has a Debt/Equity ratio of 0.98. This is a neutral value indicating ATS is somewhat dependend on debt financing.
The Debt to Equity ratio of ATS (0.98) is worse than 82.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 2.06
ROIC/WACC0.56
WACC9.82%
ATS Yearly LT Debt VS Equity VS FCFATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

ATS has a Current Ratio of 1.92. This is a normal value and indicates that ATS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ATS (1.92) is worse than 60.80% of its industry peers.
A Quick Ratio of 1.58 indicates that ATS should not have too much problems paying its short term obligations.
ATS has a better Quick ratio (1.58) than 64.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.58
ATS Yearly Current Assets VS Current LiabilitesATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for ATS have decreased strongly by -35.99% in the last year.
Measured over the past years, ATS shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.73% on average per year.
ATS shows a decrease in Revenue. In the last year, the revenue decreased by -7.46%.
The Revenue has been growing by 19.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-35.99%
EPS 3Y34.78%
EPS 5Y21.73%
EPS Q2Q%-49.48%
Revenue 1Y (TTM)-7.46%
Revenue growth 3Y28.48%
Revenue growth 5Y19.33%
Sales Q2Q%-11.52%

3.2 Future

The Earnings Per Share is expected to decrease by -1.99% on average over the next years.
ATS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.91% yearly.
EPS Next Y-44.6%
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue Next Year-10.73%
Revenue Next 2Y0.53%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ATS Yearly Revenue VS EstimatesATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ATS Yearly EPS VS EstimatesATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.60, ATS is valued on the expensive side.
ATS's Price/Earnings ratio is in line with the industry average.
ATS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.62.
A Price/Forward Earnings ratio of 19.49 indicates a rather expensive valuation of ATS.
The rest of the industry has a similar Price/Forward Earnings ratio as ATS.
ATS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.6
Fwd PE 19.49
ATS Price Earnings VS Forward Price EarningsATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ATS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.76
ATS Per share dataATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.09
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%

0

5. Dividend

5.1 Amount

No dividends for ATS!.
Industry RankSector Rank
Dividend Yield N/A

ATS CORP

NYSE:ATS (2/21/2025, 8:04:01 PM)

After market: 28.79 0 (0%)

28.79

-0.3 (-1.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)05-14 2025-05-14/amc
Inst Owners94.54%
Inst Owner ChangeN/A
Ins Owners0.8%
Ins Owner ChangeN/A
Market Cap2.82B
Analysts78.18
Price Target34.82 (20.94%)
Short Float %3.91%
Short Ratio31.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.57%
Min EPS beat(2)-22.3%
Max EPS beat(2)1.16%
EPS beat(4)2
Avg EPS beat(4)-2.23%
Min EPS beat(4)-22.3%
Max EPS beat(4)16.48%
EPS beat(8)4
Avg EPS beat(8)3.18%
EPS beat(12)6
Avg EPS beat(12)5.18%
EPS beat(16)10
Avg EPS beat(16)11.92%
Revenue beat(2)1
Avg Revenue beat(2)-2.1%
Min Revenue beat(2)-5.85%
Max Revenue beat(2)1.64%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-5.85%
Max Revenue beat(4)8.66%
Revenue beat(8)6
Avg Revenue beat(8)2.26%
Revenue beat(12)8
Avg Revenue beat(12)1.93%
Revenue beat(16)12
Avg Revenue beat(16)2.98%
PT rev (1m)-0.79%
PT rev (3m)-3.8%
EPS NQ rev (1m)-13.04%
EPS NQ rev (3m)-35.9%
EPS NY rev (1m)-15.05%
EPS NY rev (3m)-26.11%
Revenue NQ rev (1m)-2.11%
Revenue NQ rev (3m)-10.22%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-6.15%
Valuation
Industry RankSector Rank
PE 23.6
Fwd PE 19.49
P/S 1.46
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB N/A
EV/EBITDA 13.76
EPS(TTM)1.22
EY4.24%
EPS(NY)1.48
Fwd EY5.13%
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS19.78
BVpS12.61
TBVpS-2.67
PEG (NY)N/A
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 5.09%
ROCE 6.89%
ROIC 5.46%
ROICexc 5.89%
ROICexgc 16.29%
OM 8.98%
PM (TTM) 3.25%
GM 29.64%
FCFM N/A
ROA(3y)4.1%
ROA(5y)3.55%
ROE(3y)11.76%
ROE(5y)9.71%
ROIC(3y)7.85%
ROIC(5y)7.1%
ROICexc(3y)8.35%
ROICexc(5y)7.9%
ROICexgc(3y)29.75%
ROICexgc(5y)26.65%
ROCE(3y)9.91%
ROCE(5y)8.97%
ROICexcg growth 3Y6.21%
ROICexcg growth 5Y-6.28%
ROICexc growth 3Y10.14%
ROICexc growth 5Y0.41%
OM growth 3Y10.39%
OM growth 5Y3.89%
PM growth 3Y12.53%
PM growth 5Y2.52%
GM growth 3Y2.82%
GM growth 5Y1.64%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 49.76%
Cap/Sales 2.73%
Interest Coverage 3.23
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.58
Altman-Z 2.06
F-Score4
WACC9.82%
ROIC/WACC0.56
Cap/Depr(3y)57.61%
Cap/Depr(5y)59.33%
Cap/Sales(3y)2.82%
Cap/Sales(5y)2.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.99%
EPS 3Y34.78%
EPS 5Y21.73%
EPS Q2Q%-49.48%
EPS Next Y-44.6%
EPS Next 2Y-10.55%
EPS Next 3Y-1.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.46%
Revenue growth 3Y28.48%
Revenue growth 5Y19.33%
Sales Q2Q%-11.52%
Revenue Next Year-10.73%
Revenue Next 2Y0.53%
Revenue Next 3Y2.91%
Revenue Next 5YN/A
EBIT growth 1Y-22.14%
EBIT growth 3Y41.83%
EBIT growth 5Y23.97%
EBIT Next Year-5.53%
EBIT Next 3Y8.43%
EBIT Next 5YN/A
FCF growth 1Y-697.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.21%
OCF growth 3Y-51.77%
OCF growth 5Y-30.44%